Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Non-Current Assets (2019 - 2025)

Historic Non-Current Assets for Harmony Biosciences Holdings (HRMY) over the last 7 years, with Q3 2025 value amounting to $369.4 million.

  • Harmony Biosciences Holdings' Non-Current Assets fell 894.98% to $369.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $369.4 million, marking a year-over-year decrease of 894.98%. This contributed to the annual value of $419.9 million for FY2024, which is 1652.99% up from last year.
  • As of Q3 2025, Harmony Biosciences Holdings' Non-Current Assets stood at $369.4 million, which was down 894.98% from $416.7 million recorded in Q2 2025.
  • Harmony Biosciences Holdings' 5-year Non-Current Assets high stood at $419.9 million for Q4 2024, and its period low was $149.0 million during Q4 2021.
  • For the 5-year period, Harmony Biosciences Holdings' Non-Current Assets averaged around $293.9 million, with its median value being $304.5 million (2023).
  • The largest annual percentage gain for Harmony Biosciences Holdings' Non-Current Assets in the last 5 years was 11537.86% (2021), contrasted with its biggest fall of 924.52% (2021).
  • Quarter analysis of 5 years shows Harmony Biosciences Holdings' Non-Current Assets stood at $149.0 million in 2021, then soared by 83.61% to $273.6 million in 2022, then surged by 31.72% to $360.4 million in 2023, then grew by 16.53% to $419.9 million in 2024, then decreased by 12.03% to $369.4 million in 2025.
  • Its Non-Current Assets was $369.4 million in Q3 2025, compared to $416.7 million in Q2 2025 and $412.8 million in Q1 2025.